JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Peficitinib (formerly ASP015K and JNJ54781532) is a novel, potent and orally bioavailable inhibitor of Janus kinase-JAK with potential anti-inflammatory activities. It inhibits JAK1, JAK2, JAK3 and Tyk2 with IC50 values of 3.9, 5.0, 0.7 and 4.8 nM, respectively. It exhibited potent in vivo anti-rheumatoid arthritis (RA) efficacy in adjuvant-induced arthritis model in rats. In addition, ASP-015K inhibited the IL-2-induced proliferation of human T cells with IC50 of 18 nM.
References: Arthritis Rheumatol. 2016 Oct 16. doi: 10.1002/art.39955; Ann Rheum Dis. 2016 Jun; 75(6):1057-64.
Related CAS: 1353219-05-2 (HBr); 944118-01-8 (free base);
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!